Optimal COA Measurement Strategy in Modern Oncology Trials
Learn key strategies for COA measurement in oncology trials, including insights from FDA draft guidance on PROMs such as selection and implementation.
Learn key strategies for COA measurement in oncology trials, including insights from FDA draft guidance on PROMs such as selection and implementation.
Explore recent FDA guidance on PROs in oncology trials and learn how to enhance PRO data for labeling claims.
Discover the FDA's draft guidance on oncology PROs and its impact on trial design, data collection, patient experience, and outcomes.